---
figid: PMC6766623__zh20081988490012
figtitle: Molecular mechanisms by which pretreatment with monophosphoryl lipid A (MPLA)
  suppresses LPS signaling in the medullary thick ascending limb
organisms:
- Mus musculus
- Homo sapiens
pmcid: PMC6766623
filename: zh20081988490012.jpg
figlink: pmc/articles/PMC6766623/figure/F0012/
number: F12
caption: Model of molecular mechanisms by which pretreatment with monophosphoryl lipid
  A (MPLA) suppresses LPS signaling in the medullary thick ascending limb. LPS inhibits  absorption
  through activation of a basolateral Toll-like receptor 4-myeloid differentiation
  factor 88-IL-1 receptor-associated kinase-1-extracellular signal-regulated kinase
  (TLR4-MyD88-IRAK-1-ERK) pathway (, , ). MPLA activates a TLR4-Toll/IL-1 receptor
  domain-containing adaptor-inducing interferon-β (TRIF)-phosphatidylinositol 3-kinase
  (PI3K)-dependent pathway that increases expression of Toll-interacting protein (Tollip).
  Tollip, in turn, negatively regulates LPS signaling downstream of TLR4-MyD88 by
  suppressing the phosphorylation and activation of IRAK-1. Inhibition of IRAK-1 prevents
  subsequent activation of ERK that mediates LPS inhibition of  absorption (, ). Arrows
  do not necessarily imply direct relationships; regulatory steps may involve additional
  signaling components.
papertitle: Monophosphoryl lipid A induces protection against LPS in medullary thick
  ascending limb through induction of Tollip and negative regulation of IRAK-1.
reftext: Bruns A. Watts, et al. Am J Physiol Renal Physiol. 2019 Sep 1;317(3):F705-F719.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9289457
figid_alias: PMC6766623__F12
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC6766623__F12
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6766623__zh20081988490012.html
  '@type': Dataset
  description: Model of molecular mechanisms by which pretreatment with monophosphoryl
    lipid A (MPLA) suppresses LPS signaling in the medullary thick ascending limb.
    LPS inhibits  absorption through activation of a basolateral Toll-like receptor
    4-myeloid differentiation factor 88-IL-1 receptor-associated kinase-1-extracellular
    signal-regulated kinase (TLR4-MyD88-IRAK-1-ERK) pathway (, , ). MPLA activates
    a TLR4-Toll/IL-1 receptor domain-containing adaptor-inducing interferon-β (TRIF)-phosphatidylinositol
    3-kinase (PI3K)-dependent pathway that increases expression of Toll-interacting
    protein (Tollip). Tollip, in turn, negatively regulates LPS signaling downstream
    of TLR4-MyD88 by suppressing the phosphorylation and activation of IRAK-1. Inhibition
    of IRAK-1 prevents subsequent activation of ERK that mediates LPS inhibition of  absorption
    (, ). Arrows do not necessarily imply direct relationships; regulatory steps may
    involve additional signaling components.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IRF6
  - TLR4
  - TLR2
  - MYD88
  - TRIM69
  - TICAM1
  - IRAK1
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K1
  - MAP2K2
  - TOLLIP
  - MAPK3
  - MAPK1
  - Tlr4
  - Tlr2
  - Myd88
  - Rnf138
  - Trim69
  - Ticam1
  - Ticam2
  - Irak1
  - Akt1
  - Pik3r1
  - Map2k1
  - Map2k2
  - Tollip
  - Mapk3
  - Mapk1
  - IHCO3
  - LPS
---
